PSMA expression in Schwannoma: A potential clinical mimicker of metastatic prostate carcinoma

Urologic Oncology: Seminars and Original Investigations

Volumn 27, Issue 5, 2009, Pages 525-528

  Wang, Wenle ^a   Tavora, Fabio ^a   Sharma, Rajni ^a   Eisenberger, Mario ^a,b   Netto, George J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Prostate; Prostate specific membrane antigen; Schwannoma

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY PROSTATE SPECIFIC MEMBRANE ANTIGEN; PROSTATE SPECIFIC MEMBRANE ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; METASTASIS; NEURILEMOMA; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; STAINING; TUMOR CELL; TUMOR VASCULARIZATION;

ADULT; AGED; ANTIGENS, SURFACE; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEURILEMMOMA; PROSTATIC NEOPLASMS; RADIONUCLIDE IMAGING; TUMOR MARKERS, BIOLOGICAL;

EID: 69249109709     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2008.04.007     Document Type: Article

References (19)

1. Horoszewicz J.S., Kawinski E., and Murphy G.P. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res 7 5B (1987) 927-935
2. Halsted C.H., Ling E.H., Luthi-Carter R., et al. Folylpoly-γ-glutamate carboxypeptidase from pig jejunum. Molecular characterization and relation to glutamate carboxypeptidase II. J Biol Chem 273 32 (1998) 20417-20424
3. Pinto J.T., Suffoletto B.P., Berzin T.M., et al. Prostate-specific membrane antigen: A novel folate hydrolase in human prostatic carcinoma cells. Clin Cancer Res 2 9 (1996) 1445-1451
4. Chang S.S., O'Keefe D.S., Bacich D.J., et al. Prostate-specific membrane antigen is produced in tumor-associated neovasculature. Clin Cancer Res 5 10 (1999) 2674-2681
5. Baccala A., Sercia L., Li J., et al. Expression of prostate-specific membrane antigen in tumor-associated neovasculature of renal neoplasms. Urology 70 2 (2007) 385-390
6. Conway R.E., Petrovic N., Li Z., et al. Prostate-specific membrane antigen regulates angiogenesis by modulating integrin signal transduction. Molecular and cellular biology 26 14 (2006) 5310-5324
7. Foss C.A., Mease R.C., Fan H., et al. Radiolabeled small-molecule ligands for prostate-specific membrane antigen: In vivo imaging in experimental models of prostate cancer. Clin Cancer Res 11 11 (2005) 4022-4028
8. Karam J.A., Mason R.P., Koeneman K.S., et al. Molecular imaging in prostate cancer. J Cell Biochem 90 3 (2003) 473-483
9. Taneja S.S. Prostascint(R) scan: Contemporary use in clinical practice. Rev Urol 6 Suppl 10 (2004) S19-S28
10. David K.A., Milowsky M.I., Kostakoglu L., et al. Clinical utility of radiolabeled monoclonal antibodies in prostate cancer. Clin Genitourinary Cancer 4 4 (2006) 249-256
11. Bander N.H. Technology insight: Monoclonal antibody imaging of prostate cancer. Nat Clin Pract 3 4 (2006) 216-225
12. Henry M.D., Wen S., Silva M.D., et al. A prostate-specific membrane antigen-targeted monoclonal antibody-chemotherapeutic conjugate designed for the treatment of prostate cancer. Cancer Res 64 21 (2004) 7995-8001
13. Mhawech-Fauceglia P., Zhang S., Terracciano L., et al. Prostate-specific membrane antigen (PSMA) protein expression in normal and neoplastic tissues and its sensitivity and specificity in prostate adenocarcinoma: An immunohistochemical study using multiple tumor tissue microarray technique. Histopathology 50 4 (2007) 472-483
14. Kinoshita Y., Kuratsukuri K., Landas S., et al. Expression of prostate-specific membrane antigen in normal and malignant human tissues. World J Surg 30 4 (2006) 628-636
15. Marchal C., Redondo M., Padilla M., et al. Expression of prostate specific membrane antigen (PSMA) in prostatic adenocarcinoma and prostatic intraepithelial neoplasia. Histol Histopathol 19 3 (2004) 715-718
16. Chang S.S., Reuter V.E., Heston W.D., et al. Five different antiprostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature. Cancer Res 59 13 (1999) 3192-3198
17. Burger M.J., Tebay M.A., Keith P.A., et al. Expression analysis of δ-catenin and prostate-specific membrane antigen: Their potential as diagnostic markers for prostate cancer. Int J Cancer 100 2 (2002) 228-237
18. Chang S.S., Reuter V.E., Heston W.D., et al. Comparison of anti-prostate-specific membrane antigen antibodies and other immunomarkers in metastatic prostate carcinoma. Urology 57 6 (2001) 1179-1183
19. Sacha P., Zamecnik J., Barinka C., et al. Expression of glutamate carboxypeptidase II in human brain. Neuroscience 144 4 (2007) 1361-1372